---
figid: PMC5516800__nihms876825f1
figlink: /pmc/articles/PMC5516800/figure/F1/
number: Figure 1
caption: Compared with normal cells (left), the flux of glucose metabolism and glycolysis
  is accelerated in cancer cells (right) by preferential expression of transporters
  and enzyme isoforms that drive glucose flux forward and to adapt to the anabolic
  demands of cancer cells. Enzymes that catalyse the metabolic reactions are shown
  in ovals. Enzymes that are predominant in cancer cells are shown in bold. The thickness
  of the arrows indicates relative flux. 1,3BPG, 1,3-bisphosphoglycerate; 2PG, 2-phosphoglycerate;
  3PG, 3-phosphoglycerate; α-KG, α-ketoglutarate; AcCoA, acetyl-CoA; ALDO, aldolase;
  DHAP, dihydroxyacetone-phosphate; ENO, enolase; F1,6BP, fructose-1,6-bisphosphate;
  F2,6BP, fructose-2,6-bisphosphate; F6P, fructose-6-phosphate; FAS, fatty acid synthesis;
  G3P, glyceraldehyde-3-phosphate; G6P, glucose-6-phosphate; HK, hexokinase; LDH,
  lactate dehydrogenase; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GCK, glucokinase;
  GLUT, glucose transporter; glycerol-3P, glycerol-3-phosphate; GPI, glucose-6-phosphate
  isomerase; MCT, monocarboxylate transporter; OAA, oxaloacetate; PEP, phosphoenolpyruvate;
  PFK1, phosphofructokinase 1; PFKFB, 6-phosphofructo 2-kinase/fructose-2,6-bisphosphatase;
  PGAM1, phosphoglycerate mutase 1; PGK1, phosphoglycerate kinase 1; PK, pyruvate
  kinase; PPP, pentose phosphate pathway; TCA, tricarboxylic acid; TPI, triosephosphate
  isomerase.
pmcid: PMC5516800
papertitle: 'Reprogramming glucose metabolism in cancer: can it be exploited for cancer
  therapy?.'
reftext: Nissim Hay. Nat Rev Cancer. ;16(10):635-649.
pmc_ranked_result_index: '14145'
pathway_score: 0.8907756
filename: nihms876825f1.jpg
figtitle: 'Reprogramming glucose metabolism in cancer: can it be exploited for cancer
  therapy?'
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5516800__nihms876825f1.html
  '@type': Dataset
  description: Compared with normal cells (left), the flux of glucose metabolism and
    glycolysis is accelerated in cancer cells (right) by preferential expression of
    transporters and enzyme isoforms that drive glucose flux forward and to adapt
    to the anabolic demands of cancer cells. Enzymes that catalyse the metabolic reactions
    are shown in ovals. Enzymes that are predominant in cancer cells are shown in
    bold. The thickness of the arrows indicates relative flux. 1,3BPG, 1,3-bisphosphoglycerate;
    2PG, 2-phosphoglycerate; 3PG, 3-phosphoglycerate; α-KG, α-ketoglutarate; AcCoA,
    acetyl-CoA; ALDO, aldolase; DHAP, dihydroxyacetone-phosphate; ENO, enolase; F1,6BP,
    fructose-1,6-bisphosphate; F2,6BP, fructose-2,6-bisphosphate; F6P, fructose-6-phosphate;
    FAS, fatty acid synthesis; G3P, glyceraldehyde-3-phosphate; G6P, glucose-6-phosphate;
    HK, hexokinase; LDH, lactate dehydrogenase; GAPDH, glyceraldehyde-3-phosphate
    dehydrogenase; GCK, glucokinase; GLUT, glucose transporter; glycerol-3P, glycerol-3-phosphate;
    GPI, glucose-6-phosphate isomerase; MCT, monocarboxylate transporter; OAA, oxaloacetate;
    PEP, phosphoenolpyruvate; PFK1, phosphofructokinase 1; PFKFB, 6-phosphofructo
    2-kinase/fructose-2,6-bisphosphatase; PGAM1, phosphoglycerate mutase 1; PGK1,
    phosphoglycerate kinase 1; PK, pyruvate kinase; PPP, pentose phosphate pathway;
    TCA, tricarboxylic acid; TPI, triosephosphate isomerase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ALDOA
  - WDTC1
  - SLC16A7
  - ALDOB
  - SLC2A1
  - PFKM
  - SLC2A3
  - SLC2A2
  - GPI
  - ENO3
  - F2
  - SLC2A4
  - GAPDH
  - PAEP
  - GCK
  - FAS
  - PFKFB2
  - PFKFB3
  - MCTS1
  - PFKFB1
  - ENO1
  - LDHB
  - ENO2
  - GIT2
  - HK1
  - HK2
  - PGK1
  - PFKFB4
  - EIF2AK2
  - ENO4
  - PKM
  - LDHA
  - Fumarate
  - Glucose
  - Glycerol
  - Glycerol-3P
  - Hexosamine
  - Pyruvate
  - Serine
  - Succinate
  - Lactate
genes:
- word: ALDOA,
  symbol: ALDOA
  source: hgnc_symbol
  hgnc_symbol: ALDOA
  entrez: '226'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: MCT1-4
  symbol: MCT2
  source: hgnc_alias_symbol
  hgnc_symbol: SLC16A7
  entrez: '9194'
- word: ALDOB
  symbol: ALDOB
  source: hgnc_symbol
  hgnc_symbol: ALDOB
  entrez: '229'
- word: GLUT1-4
  symbol: GLUT1
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A1
  entrez: '6513'
- word: PFK1
  symbol: PFK-1
  source: hgnc_alias_symbol
  hgnc_symbol: PFKM
  entrez: '5213'
- word: GLUT1-4
  symbol: GLUT3
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A3
  entrez: '6515'
- word: GLUT1-4
  symbol: GLUT2
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A2
  entrez: '6514'
- word: GPI
  symbol: GPI
  source: hgnc_symbol
  hgnc_symbol: GPI
  entrez: '2821'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO3
  entrez: '2027'
- word: F2,6BP
  symbol: F2
  source: hgnc_symbol
  hgnc_symbol: F2
  entrez: '2147'
- word: GLUT1-4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: GAPDH
  symbol: GAPDH
  source: hgnc_symbol
  hgnc_symbol: GAPDH
  entrez: '2597'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: HK1,HK2,GCK
  symbol: GCK
  source: hgnc_symbol
  hgnc_symbol: GCK
  entrez: '2645'
- word: FAS
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: PFKFB1-4
  symbol: PFKFB2
  source: hgnc_symbol
  hgnc_symbol: PFKFB2
  entrez: '5208'
- word: PFKFB3,
  symbol: PFKFB3
  source: hgnc_symbol
  hgnc_symbol: PFKFB3
  entrez: '5209'
- word: MCT1-4
  symbol: MCT-1
  source: hgnc_alias_symbol
  hgnc_symbol: MCTS1
  entrez: '28985'
- word: PFKFB1-4
  symbol: PFKFB1
  source: hgnc_symbol
  hgnc_symbol: PFKFB1
  entrez: '5207'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO1
  entrez: '2023'
- word: LDHB
  symbol: LDHB
  source: hgnc_symbol
  hgnc_symbol: LDHB
  entrez: '3945'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO2
  entrez: '2026'
- word: PKR,PKL
  symbol: PKL
  source: hgnc_alias_symbol
  hgnc_symbol: GIT2
  entrez: '9815'
- word: HK1,HK2,GCK
  symbol: HK1
  source: hgnc_symbol
  hgnc_symbol: HK1
  entrez: '3098'
- word: HK2,
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: PGK1
  symbol: PGK1
  source: hgnc_symbol
  hgnc_symbol: PGK1
  entrez: '5230'
- word: PFKFB4
  symbol: PFKFB4
  source: hgnc_symbol
  hgnc_symbol: PFKFB4
  entrez: '5210'
- word: PKR,PKL
  symbol: PKR
  source: hgnc_alias_symbol
  hgnc_symbol: EIF2AK2
  entrez: '5610'
- word: ENO
  symbol: ENO
  source: bioentities_symbol
  hgnc_symbol: ENO4
  entrez: '387712'
- word: PKM1,PKM2,
  symbol: PKM2
  source: hgnc_prev_symbol
  hgnc_symbol: PKM
  entrez: '5315'
- word: LDHA.
  symbol: LDHA
  source: hgnc_symbol
  hgnc_symbol: LDHA
  entrez: '3939'
chemicals:
- word: Fumarate
  source: MESH
  identifier: D005650
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glycerol
  source: MESH
  identifier: D005990
- word: Glycerol-3P
  source: MESH
  identifier: D005990
- word: Hexosamine
  source: MESH
  identifier: D006595
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: Serine
  source: MESH
  identifier: D012694
- word: Succinate
  source: MESH
  identifier: D013386
- word: Lactate
  source: MESH
  identifier: D019344
diseases: []
---
